Coronavirus vaccine developer CureVac raises $213.3 mln in U.S. IPO - Reuters

3:27am PDT - August 14th, 2020    stock-market - Reuters

CureVac BV said on Friday it raised $213.3 million in its initial public offering in New York, setting the stage for the first stock market debut of a company developing a potential vaccine to combat the coronavirus.